- Report
- April 2023
- 86 Pages
Europe
From €4281EUR$4,400USD£3,667GBP
- Report
- May 2021
- 48 Pages
Global
€1282EUR$1,318USD£1,099GBP
- Report
- February 2022
- 120 Pages
Global
From €2432EUR$2,500USD£2,084GBP
- Report
- June 2021
- 120 Pages
Global
From €2432EUR$2,500USD£2,084GBP
- Report
- February 2021
- 120 Pages
Global
From €2432EUR$2,500USD£2,084GBP
- Report
- August 2022
United States
From €1888EUR$1,940USD£1,617GBP
- Report
- August 2022
United States
From €1888EUR$1,940USD£1,617GBP
- Report
- August 2022
Global
From €1061EUR$1,090USD£909GBP
- Report
- August 2022
Global
From €769EUR$790USD£658GBP
- Report
- February 2021
Global
From €2880EUR$2,960USD£2,467GBP
- Report
- February 2021
Global
From €2880EUR$2,960USD£2,467GBP
- Report
- August 2021
Europe
From €3328EUR$3,420USD£2,851GBP
- Report
- August 2021
Europe
From €3328EUR$3,420USD£2,851GBP
- Report
- August 2021
Global
From €3882EUR$3,990USD£3,326GBP
- Report
- August 2021
Global
From €3882EUR$3,990USD£3,326GBP
- Clinical Trials
- February 2021
- 267 Pages
Global
From €2432EUR$2,500USD£2,084GBP
- Clinical Trials
- August 2021
- 246 Pages
Global
From €2432EUR$2,500USD£2,084GBP
- Drug Pipelines
- November 2020
- 829 Pages
Global
From €1946EUR$2,000USD£1,667GBP
- Drug Pipelines
- August 2020
- 419 Pages
Global
From €1946EUR$2,000USD£1,667GBP
- Drug Pipelines
- July 2020
- 33 Pages
Global
From €3405EUR$3,500USD£2,917GBP
Sarcoma is a type of cancer that affects the connective tissues of the body, such as muscle, bone, fat, and blood vessels. Sarcoma drugs are used to treat this type of cancer, and are part of the larger oncology drug market. These drugs are typically used in combination with other treatments, such as surgery, radiation, and chemotherapy. Sarcoma drugs are designed to target the specific type of cancer, and can be used to reduce the size of tumors, slow the growth of cancer cells, and reduce the risk of metastasis.
The sarcoma drug market is highly competitive, with many companies developing new treatments and therapies. Some of the major players in the market include Pfizer, Merck, Novartis, Bristol-Myers Squibb, and Eli Lilly. Other companies, such as Amgen, AstraZeneca, and Celgene, are also developing treatments for sarcoma. Show Less Read more